Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections.

Moiton, M P; Richez, C; Dumoulin, C; Mehsen, N; Dehais, J; Schaeverbeke, T

Moiton, M P; Richez, C; Dumoulin, C; Mehsen, N; Dehais, J; Schaeverbeke, T.

Clin Microbiol Infect ; 12(12): 1151-3, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17121619

Subject(s)

Anti-Inflammatory Agents/adverse effects; Antibodies, Monoclonal/adverse effects; Opportunistic Infections/immunology; Tuberculosis/immunology; Tumor Necrosis Factor-alpha/antagonists & inhibitors; Anti-Inflammatory Agents/therapeutic use; Antibodies, Monoclonal/therapeutic use; Arthritis, Rheumatoid/drug therapy; Crohn Disease/drug therapy; Humans; Incidence; Infliximab; Opportunistic Infections/epidemiology; Tuberculosis/epidemiology; Tumor Necrosis Factor-alpha/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Opportunistic Infections / Tumor Necrosis Factor-alpha / Anti-Inflammatory Agents / Antibodies, Monoclonal Type of study: Incidence_studies / Prognostic_studies Limits: Humans Language: En Journal: Clin Microbiol Infect Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2006 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links